1015 Capital Partners »

United Therapeutics Corporation shares owned by 1015 Capital Partners

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by 1015 Capital Partners from 13F filings

Historical chart of 1015 Capital Partners investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by 1015 Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by 1015 Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $21k 36 592.97
2025-12-31 $18k 36 487.25

More positions owned by 1015 Capital Partners

Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Vanguard Total Stock Market Etf Etf (VTI)
Nvidia Corporation Stock (NVDA)
Ishares Short-term National Muni Bond Etf Etf (SUB)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
State Street Spdr S&p 500 Etf Etf (SPY)
Vanguard High Dividend Yield Index Etf Etf (VYM)
Ishares Msci Eafe Etf Etf (EFA)
Jpmorgan Municipal Etf Etf (JMUB)
Jpmorgan International Research Enhanced Equity Etf Etf (JIRE)
Ishares Core Msci Eafe Etf Etf (IEFA)
State Street Spdr S&p Dividend Etf Etf (SDY)
Ishares Esg Msci Kld 400 Etf Etf (DSI)

View all positions for 1015 Capital Partners

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Renaissance Technologies
State Street Corporation
Geode Capital Management
Henderson Group
AQR Capital Management
Citadel Advisors
Assetmark
Invesco
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation